Skip to main content
Log in

Blase außer Kontrolle

Ratschläge für Frauen mit Harninkontinenz

Urinary incontinence in women

  • FORTBILDUNG_ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Eine Harninkontinenz — egal welcher Ursache — ist für die Betroffenen immer sehr peinlich und wirkt sich somit gravierend auf ihre Lebensqualität aus. Lesen Sie im nachfolgenden Beitrag, wann ein konservativer Therapieversuch, z. B. Beckenbodentraining, Erfolg verspricht, wann Medikamente helfen und welche neueren operativen Verfahren, z. B. Mini-Schlingen, empfehlenswert sind.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Lucas, M.G., et al., EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol, 2012. 62(6): p. 1130–42.

    Article  PubMed  Google Scholar 

  2. Chen, C.C., et al., Obesity is associated with increased prevalence and severity of pelvic floor disorders in women considering bariatric surgery. Surg Obes Relat Dis, 2009. 5(4): p. 411–5.

    Article  PubMed  Google Scholar 

  3. Auwad, W., et al., Moderate weight loss in obese women with urinary incontinence: a prospective longitudinal study. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19(9): p. 1251–9.

    Article  PubMed  Google Scholar 

  4. Hay-Smith, E.J. and C. Dumoulin, Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev, 2006(1): p. CD005654.

  5. Duckett, J.R., et al., Tolerability and efficacy of duloxetine in a nontrial situation. BJOG, 2007. 114(5): p. 543–7.

    Article  CAS  PubMed  Google Scholar 

  6. Mariappan, P., et al., Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol, 2007. 51(1): p. 67–74.

    Article  CAS  PubMed  Google Scholar 

  7. Shamliyan, T.A., et al., Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med, 2008. 148(6): p. 459–73.

    Article  PubMed  Google Scholar 

  8. Lucas, M.G., et al., EAU guidelines on surgical treatment of urinary incontinence. Eur Urol, 2012. 62(6): p. 1118–29.

    Article  PubMed  Google Scholar 

  9. Lapitan, M.C., J.D. Cody, and A. Grant, Open retropubic colposuspension for urinary incontinence in women: a short version Cochrane review. Neurourol Urodyn, 2009. 28(6): p. 472–80

    Article  PubMed  Google Scholar 

  10. Giberti, C., et al., The suburethral tension adjustable sling (REMEEX system) in the treatment of female urinary incontinence due to 'true' intrinsic sphincter deficiency: results after 5 years of mean follow-up. BJU Int, 2011. 108(7): p. 1140–4.

    Article  PubMed  Google Scholar 

  11. Errando, C., et al., A re-adjustable sling for female recurrent stress incontinence and sphincteric deficiency: Outcomes and complications in 125 patients using the Remeex sling system. Neurourol Urodyn, 2010. 29(8): p. 1429–32.

    Article  PubMed  Google Scholar 

  12. Reisenauer, C., et al., Interdisciplinary S2e Guideline for the Diagnosis and Treatment of Stress Urinary Incontinence in Women: Short version - AWMF Registry No. 015-005, July 2013. Geburtshilfe Frauenheilkd, 2013. 73(9): p. 899–903.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Cardozo, L., et al., A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand, 2004. 83(10): p. 892–7.

    Article  PubMed  Google Scholar 

  14. Andersson, K.E., Antimuscarinics for treatment of overactive bladder. Lancet Neurol, 2004. 3(1): p. 46–53.

    Article  CAS  PubMed  Google Scholar 

  15. Wagg, A., et al., Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study. Eur Urol, 2013. 64(1): p. 74–81.

    Article  CAS  PubMed  Google Scholar 

  16. Wagg, A., et al., Long-term safety, tolerability and efficacy of flexible-dose fesoterodine in elderly patients with overactive bladder: open-label extension of the SOFIA trial. Neurourol Urodyn, 2014. 33(1): p. 106–14.

    Article  CAS  PubMed  Google Scholar 

  17. Dubeau, C.E., et al., Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: a double-blind, placebo controlled trial. J Urol, 2014. 191(2): p. 395–404.

    Article  CAS  PubMed  Google Scholar 

  18. Chapple, C.R., et al., Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a beta(3)-adrenoceptor agonist, in overactive bladder. Eur Urol, 2013. 63(2): p. 296–305.

    Article  CAS  PubMed  Google Scholar 

  19. Khullar, V., et al., Efficacy and tolerability of mirabegron, a beta(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial. Eur Urol, 2013. 63(2): p. 283–95.

    Article  CAS  PubMed  Google Scholar 

  20. Nitti, V.W., et al., OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol, 2013. 189(6): p. 2186–93.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Kretschmer.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kretschmer, A., Grabbert, M.T., Stief, C.G. et al. Ratschläge für Frauen mit Harninkontinenz. MMW - Fortschritte der Medizin 157, 48–52 (2015). https://doi.org/10.1007/s15006-015-3478-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-015-3478-3

Keywords

Navigation